Nina E. Forestieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nina E. Forestieri has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Eirini Nestoridi
Massachusetts Birth Defects Monitoring Program Massachusetts Department of Public Health Boston Massachusetts USA
5 shared publications- Paul Anthony Romitti
Department of Epidemiology, College of Public Health University of Iowa Iowa City Iowa USA
4 shared publications - Philip J. Lupo
Department of Pediatrics Emory University School of Medicine Atlanta Georgia USA
4 shared publications - Rebecca F. Liberman
Massachusetts Department of Public Health, Center for Birth Defects Research and Prevention, Boston, Massachusetts
4 shared publications - Wendy N. Nembhard
Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, USA
4 shared publications - Andrew F. Olshan
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
3 shared publications
Latest Publications
- 12 December 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (12) , e70005
Evaluation of Data Sources for Critical Congenital Heart Defect Case Ascertainment in North Carolina
Background: Surveillance of critical congenital heart defects (CCHDs) is important for research and public health practice. The recent implementation of universal pulse oximetry (POX) screening may provide an additional resource for improving the completeness of CCHD surveillance data. This analysis evaluates the utility of multiple data sources, including POX records, for CCHD case identification. Methods: Using the cohort of CCHD cases confirmed by the North Carolina Birth Defects Monitoring Program born 2018–2021 ( N = 1035), sensitivity values were calculated for birth, infant death, and fetal death certificates; hospital discharge records; and POX records. Sensitivity was defined as the percentage of confirmed CCHD cases identifiable from a given data source. Sensitivity values were also stratified by demographic and clinical characteristics of cases. Results: The sensitivity of the data sources for case identification varied widely: birth certificate (6.7%; 95% confidence interval [CI]: 5.1–8.3); fetal death certificate (29.8%; 95% CI: 18.0–41.7); POX record (59.5%; 95% CI: 56.2–62.8); infant death certificate (73.0%; 95% CI: 66.7–79.3); and discharge record (89.9%; 95% CI: 88.0–91.8). Sensitivity values for some data sources were significantly higher for cases delivered in larger hospitals, transferred after delivery, admitted to the neonatal intensive care unit, or prenatally diagnosed. Conclusions: The POX record was only moderately sensitive, in part due to missing records, limiting its added value for case finding, though improvements in reporting may increase its utility. To help optimize staff time and resources, surveillance programs should consider the utility of supplemental data sources for CCHD case ascertainment.
- 12 December 2025
- Published by Wiley in Birth Defects Research
- Vol. 117 (12) , e70005
Evaluation of Data Sources for Critical Congenital Heart Defect Case Ascertainment in North Carolina
Background: Surveillance of critical congenital heart defects (CCHDs) is important for research and public health practice. The recent implementation of universal pulse oximetry (POX) screening may provide an additional resource for improving the completeness of CCHD surveillance data. This analysis evaluates the utility of multiple data sources, including POX records, for CCHD case identification. Methods: Using the cohort of CCHD cases confirmed by the North Carolina Birth Defects Monitoring Program born 2018–2021 ( N = 1035), sensitivity values were calculated for birth, infant death, and fetal death certificates; hospital discharge records; and POX records. Sensitivity was defined as the percentage of confirmed CCHD cases identifiable from a given data source. Sensitivity values were also stratified by demographic and clinical characteristics of cases. Results: The sensitivity of the data sources for case identification varied widely: birth certificate (6.7%; 95% confidence interval [CI]: 5.1–8.3); fetal death certificate (29.8%; 95% CI: 18.0–41.7); POX record (59.5%; 95% CI: 56.2–62.8); infant death certificate (73.0%; 95% CI: 66.7–79.3); and discharge record (89.9%; 95% CI: 88.0–91.8). Sensitivity values for some data sources were significantly higher for cases delivered in larger hospitals, transferred after delivery, admitted to the neonatal intensive care unit, or prenatally diagnosed. Conclusions: The POX record was only moderately sensitive, in part due to missing records, limiting its added value for case finding, though improvements in reporting may increase its utility. To help optimize staff time and resources, surveillance programs should consider the utility of supplemental data sources for CCHD case ascertainment.
- 12 December 2024
- Published by Wiley in Birth Defects Research
- Vol. 116 (12) , e2424
Observed Prevalence of Congenital Situs Inversus in the United States Before and During the SARS‐CoV‐2 Pandemic, 2017–2022
Background: Reports from China describe an increase in the frequency of fetal situs inversus in 2023 after the country's “zero‐Covid” policy was lifted, suggesting an association with maternal SARS‐CoV‐2 infection. However, a report of birth defects surveillance data from Scandinavia observed no sustained increase during the SARS‐CoV‐2 pandemic (2020–2022 vs. 2018–2019). We examined birth defects surveillance data to assess any increase in situs inversus in the U.S. during the SARS‐CoV‐2 pandemic.Methods: We combined data from four population‐based birth defects programs in Massachusetts, Minnesota, North Carolina, and Atlanta, Georgia, to compare the prevalence of situs inversus among infants and fetuses delivered before (2017–2019) and during (2021–2022) the SARS‐CoV‐2 pandemic. We defined situs inversus as mirror‐image transposition of the heart and/or other organs, or primary ciliary dyskinesis with situs inversus, excluding isolated dextrocardia. The programs varied in the pregnancy outcomes included (live births ± non‐live births); all included both prenatal and postnatal diagnoses.Results: We identified 294 infants and fetuses with situs inversus (6.8% non‐live births). We estimated the combined prevalence per 10,000 live births as 1.72 during the pandemic versus 1.71 before the pandemic (OR = 1.005; 95% CI: 0.778–1.297). The estimated annual prevalence ranged from 1.41 in 2017 to 2.21 in 2019 with no significant trend across the study period (p = 0.39).Conclusions: We did not observe an increase in situs inversus during the SARS‐CoV‐2 pandemic. Because information about SARS‐CoV‐2 infection among individual pregnancies was not available from all programs, we could not assess a specific association with maternal infection.
- 12 December 2024
- Published by Wiley in Birth Defects Research
- Vol. 116 (12) , e2424
Observed Prevalence of Congenital Situs Inversus in the United States Before and During the SARS‐CoV‐2 Pandemic, 2017–2022
Background: Reports from China describe an increase in the frequency of fetal situs inversus in 2023 after the country's “zero‐Covid” policy was lifted, suggesting an association with maternal SARS‐CoV‐2 infection. However, a report of birth defects surveillance data from Scandinavia observed no sustained increase during the SARS‐CoV‐2 pandemic (2020–2022 vs. 2018–2019). We examined birth defects surveillance data to assess any increase in situs inversus in the U.S. during the SARS‐CoV‐2 pandemic.Methods: We combined data from four population‐based birth defects programs in Massachusetts, Minnesota, North Carolina, and Atlanta, Georgia, to compare the prevalence of situs inversus among infants and fetuses delivered before (2017–2019) and during (2021–2022) the SARS‐CoV‐2 pandemic. We defined situs inversus as mirror‐image transposition of the heart and/or other organs, or primary ciliary dyskinesis with situs inversus, excluding isolated dextrocardia. The programs varied in the pregnancy outcomes included (live births ± non‐live births); all included both prenatal and postnatal diagnoses.Results: We identified 294 infants and fetuses with situs inversus (6.8% non‐live births). We estimated the combined prevalence per 10,000 live births as 1.72 during the pandemic versus 1.71 before the pandemic (OR = 1.005; 95% CI: 0.778–1.297). The estimated annual prevalence ranged from 1.41 in 2017 to 2.21 in 2019 with no significant trend across the study period (p = 0.39).Conclusions: We did not observe an increase in situs inversus during the SARS‐CoV‐2 pandemic. Because information about SARS‐CoV‐2 infection among individual pregnancies was not available from all programs, we could not assess a specific association with maternal infection.
- 11 September 2024
- Published by Wiley in Birth Defects Research
- Vol. 116 (9) , e2394
Survival of Children With Critical Congenital Heart Defects in the National Birth Defects Prevention Study
Background: Critical congenital heart defects (CCHDs) are associated with considerable morbidity and mortality. This study estimated survival of children with nonsyndromic CCHDs and evaluated relationships between exposures of interest and survival by CCHD severity (univentricular or biventricular function).Methods: This analysis included 4380 infants with CCHDs (cases) born during 1999–2011 and enrolled in the National Birth Defects Prevention Study, a multisite, population‐based case–control study of major birth defects. Cases were linked to state death files. Nonparametric Kaplan–Meier survival functions were used to estimate 1‐ and 5‐year survival probabilities overall and by severity group (univentricular/biventricular) stratified by demographic and clinical exposure variables of interest. The log‐rank test was used to determine whether stratified survival curves were equivalent. Survival and 95% confidence intervals (CIs) were also estimated using Cox proportional hazards modeling adjusted for maternal age, education, race/ethnicity, study site, and birth year.Results: One‐ and five‐year survival rates were 85.8% (CI 84.7–86.8) and 83.7% (CI 82.5–84.9), respectively. Univentricular 5‐year survival was lower than biventricular case survival [65.3% (CI 61.7–68.5) vs. 89.0% (CI 87.8–90.1; p < 0.001)]. Clinical factors (e.g. preterm birth, low birthweight, and complex/multiple defects) were associated with lower survival in each severity group. Sociodemographic factors (non‐Hispanic Black race/ethnicity, <high school education, smoking, and lower household income) were only associated with survival among biventricular cases.Conclusions: Mortality among children with CCHDs occurred primarily in the first year of life. Survival was lower for those with univentricular defects, and social determinants of health were most important in predicting survival for those with biventricular defects.
- 11 September 2024
- Published by Wiley in Birth Defects Research
- Vol. 116 (9) , e2394
Survival of Children With Critical Congenital Heart Defects in the National Birth Defects Prevention Study
Background: Critical congenital heart defects (CCHDs) are associated with considerable morbidity and mortality. This study estimated survival of children with nonsyndromic CCHDs and evaluated relationships between exposures of interest and survival by CCHD severity (univentricular or biventricular function).Methods: This analysis included 4380 infants with CCHDs (cases) born during 1999–2011 and enrolled in the National Birth Defects Prevention Study, a multisite, population‐based case–control study of major birth defects. Cases were linked to state death files. Nonparametric Kaplan–Meier survival functions were used to estimate 1‐ and 5‐year survival probabilities overall and by severity group (univentricular/biventricular) stratified by demographic and clinical exposure variables of interest. The log‐rank test was used to determine whether stratified survival curves were equivalent. Survival and 95% confidence intervals (CIs) were also estimated using Cox proportional hazards modeling adjusted for maternal age, education, race/ethnicity, study site, and birth year.Results: One‐ and five‐year survival rates were 85.8% (CI 84.7–86.8) and 83.7% (CI 82.5–84.9), respectively. Univentricular 5‐year survival was lower than biventricular case survival [65.3% (CI 61.7–68.5) vs. 89.0% (CI 87.8–90.1; p < 0.001)]. Clinical factors (e.g. preterm birth, low birthweight, and complex/multiple defects) were associated with lower survival in each severity group. Sociodemographic factors (non‐Hispanic Black race/ethnicity, <high school education, smoking, and lower household income) were only associated with survival among biventricular cases.Conclusions: Mortality among children with CCHDs occurred primarily in the first year of life. Survival was lower for those with univentricular defects, and social determinants of health were most important in predicting survival for those with biventricular defects.
- Open Access
Spatiotemporal Trends of Birth Defects in North Carolina, 2003-2015
Birth defects are a leading cause of infant mortality in the United States, but little is known about causes of many types of birth defects. Spatiotemporal disease mapping to identify high-prevalence areas, is a potential strategy to narrow the search for potential environmental and other causes that aggregate over space and time. We described the spatial and temporal trends of the prevalence of birth defects in North Carolina during 2003-2015, using data on live births obtained from the North Carolina Birth Defects Monitoring Program. By employing a Bayesian space-time Poisson model, we estimated spatial and temporal trends of non-chromosomal and chromosomal birth defects. During 2003-2015, 52,524 (3.3%) of 1,598,807 live births had at least one recorded birth defect. The prevalence of non-chromosomal birth defects decreased from 3.8% in 2003 to 2.9% in 2015. Spatial modeling suggested a large geographic variation in non-chromosomal birth defects at census-tract level, with the highest prevalence in south-eastern North Carolina. The strong spatial heterogeneity revealed in this work allowed to identify geographic areas with higher prevalence of non-chromosomal birth defects in North Carolina. This variation will help inform future research focused on epidemiologic studies of birth defects to identify etiologic factors.
Open AccessSpatiotemporal Trends of Birth Defects in North Carolina, 2003-2015
Birth defects are a leading cause of infant mortality in the United States, but little is known about causes of many types of birth defects. Spatiotemporal disease mapping to identify high-prevalence areas, is a potential strategy to narrow the search for potential environmental and other causes that aggregate over space and time. We described the spatial and temporal trends of the prevalence of birth defects in North Carolina during 2003-2015, using data on live births obtained from the North Carolina Birth Defects Monitoring Program. By employing a Bayesian space-time Poisson model, we estimated spatial and temporal trends of non-chromosomal and chromosomal birth defects. During 2003-2015, 52,524 (3.3%) of 1,598,807 live births had at least one recorded birth defect. The prevalence of non-chromosomal birth defects decreased from 3.8% in 2003 to 2.9% in 2015. Spatial modeling suggested a large geographic variation in non-chromosomal birth defects at census-tract level, with the highest prevalence in south-eastern North Carolina. The strong spatial heterogeneity revealed in this work allowed to identify geographic areas with higher prevalence of non-chromosomal birth defects in North Carolina. This variation will help inform future research focused on epidemiologic studies of birth defects to identify etiologic factors.
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e212
MATERNAL, REPRODUCTIVE, AND PERINATAL FACTORS AND THE RISKS OF BIRTH DEFECTS
- 6 October 2023
- Published by Elsevier in Fertility and Sterility
- Vol. 120 (4) , e212
MATERNAL, REPRODUCTIVE, AND PERINATAL FACTORS AND THE RISKS OF BIRTH DEFECTS
- 26 July 2023
- Published by Wiley in Birth Defects Research
- Vol. 116 (1)
Scientific impact of the National Birth Defects Prevention Network multistate collaborative publications
Background: Given the lack of a national, population‐based birth defects surveillance program in the United States, the National Birth Defects Prevention Network (NBDPN) has facilitated important studies on surveillance, research, and prevention of major birth defects. We sought to summarize NBDPN peer‐reviewed publications and their impact.Methods: We obtained and reviewed a curated list of 49 NBDPN multistate collaborative publications during 2000–2022, as of December 31, 2022. Each publication was reviewed and classified by type (e.g., risk factor association analysis). Key characteristics of study populations and analytic approaches used, along with publication impact (e.g., number of citations), were tabulated.Results: NBDPN publications focused on prevalence estimates (N = 17), surveillance methods (N = 11), risk factor associations (N = 10), mortality and other outcomes among affected individuals (N = 6), and descriptive epidemiology of various birth defects (N = 5). The most cited publications were those that reported on prevalence estimates for a spectrum of defects and those that assessed changes in neural tube defects (NTD) prevalence following mandatory folic acid fortification in the United States.Conclusions: Results from multistate NBDPN publications have provided critical information not available through other sources, including US prevalence estimates of major birth defects, folic acid fortification and NTD prevention, and improved understanding of defect trends and surveillance efforts. Until a national birth defects surveillance program is established in the United States, NBDPN collaborative publications remain an important resource for investigating birth defects and informing decisions related to health services planning of secondary disabilities prevention and care.
- 26 July 2023
- Published by Wiley in Birth Defects Research
- Vol. 116 (1)
Scientific impact of the National Birth Defects Prevention Network multistate collaborative publications
Background: Given the lack of a national, population‐based birth defects surveillance program in the United States, the National Birth Defects Prevention Network (NBDPN) has facilitated important studies on surveillance, research, and prevention of major birth defects. We sought to summarize NBDPN peer‐reviewed publications and their impact.Methods: We obtained and reviewed a curated list of 49 NBDPN multistate collaborative publications during 2000–2022, as of December 31, 2022. Each publication was reviewed and classified by type (e.g., risk factor association analysis). Key characteristics of study populations and analytic approaches used, along with publication impact (e.g., number of citations), were tabulated.Results: NBDPN publications focused on prevalence estimates (N = 17), surveillance methods (N = 11), risk factor associations (N = 10), mortality and other outcomes among affected individuals (N = 6), and descriptive epidemiology of various birth defects (N = 5). The most cited publications were those that reported on prevalence estimates for a spectrum of defects and those that assessed changes in neural tube defects (NTD) prevalence following mandatory folic acid fortification in the United States.Conclusions: Results from multistate NBDPN publications have provided critical information not available through other sources, including US prevalence estimates of major birth defects, folic acid fortification and NTD prevention, and improved understanding of defect trends and surveillance efforts. Until a national birth defects surveillance program is established in the United States, NBDPN collaborative publications remain an important resource for investigating birth defects and informing decisions related to health services planning of secondary disabilities prevention and care.
- 15 March 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (5) , 1339-1349
Prevalence and descriptive epidemiology of Turner syndrome in the United States, 2000–2017: A report from the National Birth Defects Prevention Network
The lack of United States population‐based data on Turner syndrome limits assessments of prevalence and associated characteristics for this sex chromosome abnormality. Therefore, we collated 2000–2017 data from seven birth defects surveillance programs within the National Birth Defects Prevention Network. We estimated the prevalence of karyotype‐confirmed Turner syndrome diagnosed within the first year of life. We also calculated the proportion of cases with commonly ascertained birth defects, assessed associations with maternal and infant characteristics using prevalence ratios (PR) with 95% confidence intervals (CI), and estimated survival probability. The prevalence of Turner syndrome of any pregnancy outcome was 3.2 per 10,000 female live births (95% CI = 3.0–3.3, program range: 1.0–10.4), and 1.9 for live birth and stillbirth (≥20 weeks gestation) cases (95% CI = 1.8–2.1, program range: 0.2–3.9). Prevalence was lowest among cases born to non‐Hispanic Black women compared to non‐Hispanic White women (PR = 0.5, 95% CI = 0.4–0.6). Coarctation of the aorta was the most common defect (11.6% of cases), and across the cohort, individuals without hypoplastic left heart had a five‐year survival probability of 94.6%. The findings from this population‐based study may inform surveillance practices, prenatal counseling, and diagnosis. We also identified racial and ethnic disparities in prevalence, an observation that warrants further investigation.
- 15 March 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 191 (5) , 1339-1349
Prevalence and descriptive epidemiology of Turner syndrome in the United States, 2000–2017: A report from the National Birth Defects Prevention Network
The lack of United States population‐based data on Turner syndrome limits assessments of prevalence and associated characteristics for this sex chromosome abnormality. Therefore, we collated 2000–2017 data from seven birth defects surveillance programs within the National Birth Defects Prevention Network. We estimated the prevalence of karyotype‐confirmed Turner syndrome diagnosed within the first year of life. We also calculated the proportion of cases with commonly ascertained birth defects, assessed associations with maternal and infant characteristics using prevalence ratios (PR) with 95% confidence intervals (CI), and estimated survival probability. The prevalence of Turner syndrome of any pregnancy outcome was 3.2 per 10,000 female live births (95% CI = 3.0–3.3, program range: 1.0–10.4), and 1.9 for live birth and stillbirth (≥20 weeks gestation) cases (95% CI = 1.8–2.1, program range: 0.2–3.9). Prevalence was lowest among cases born to non‐Hispanic Black women compared to non‐Hispanic White women (PR = 0.5, 95% CI = 0.4–0.6). Coarctation of the aorta was the most common defect (11.6% of cases), and across the cohort, individuals without hypoplastic left heart had a five‐year survival probability of 94.6%. The findings from this population‐based study may inform surveillance practices, prenatal counseling, and diagnosis. We also identified racial and ethnic disparities in prevalence, an observation that warrants further investigation.
- 30 July 2022
- Published by Wiley in Birth Defects Research
- Vol. 114 (14) , 805-811
Prevalence of individual brain and eye defects potentially related to Zika virus in pregnancy in 22 U.S. states and territories, January 2016 to June 2017
During the Centers for Disease Control and Prevention's Zika Virus Response, birth defects surveillance programs adapted to monitor birth defects potentially related to Zika virus (ZIKV) infection during pregnancy. Pregnancy outcomes occurring during January 2016 to June 2017 in 22 U.S. states and territories were used to estimate the prevalence of those brain and eye defects potentially related to ZIKV. Jurisdictions were divided into three groups: areas with widespread ZIKV transmission, areas with limited local ZIKV transmission, and areas without local ZIKV transmission. Prevalence estimates for selected brain and eye defects and microcephaly per 10,000 live births were estimated. Prevalence ratios (PRs) and 95% confidence intervals (CIs) were estimated using Poisson regression for areas with widespread and limited ZIKV transmission compared with areas without local ZIKV transmission. Defects with significantly higher prevalence in areas of widespread transmission were pooled, and PRs were calculated by quarter, comparing subsequent quarters to the first quarter (January-March 2016). Nine defects had significantly higher prevalence in areas of widespread transmission. The highest PRs were seen in intracranial calcifications (PR = 12.6, 95% CI [7.4, 21.3]), chorioretinal abnormalities (12.5 [7.1, 22.3]), brainstem abnormalities (9.3 [4.7, 18.4]), and cerebral/cortical atrophy (6.7 [4.2, 10.8]). The PR of the nine pooled defects was significantly higher in three quarters in areas with widespread transmission. The largest difference in prevalence was observed for defects consistently reported in infants with congenital ZIKV infection. Birth defects surveillance programs could consider monitoring a subset of birth defects potentially related to ZIKV in pregnancy.
- 30 July 2022
- Published by Wiley in Birth Defects Research
- Vol. 114 (14) , 805-811
Prevalence of individual brain and eye defects potentially related to Zika virus in pregnancy in 22 U.S. states and territories, January 2016 to June 2017
During the Centers for Disease Control and Prevention's Zika Virus Response, birth defects surveillance programs adapted to monitor birth defects potentially related to Zika virus (ZIKV) infection during pregnancy. Pregnancy outcomes occurring during January 2016 to June 2017 in 22 U.S. states and territories were used to estimate the prevalence of those brain and eye defects potentially related to ZIKV. Jurisdictions were divided into three groups: areas with widespread ZIKV transmission, areas with limited local ZIKV transmission, and areas without local ZIKV transmission. Prevalence estimates for selected brain and eye defects and microcephaly per 10,000 live births were estimated. Prevalence ratios (PRs) and 95% confidence intervals (CIs) were estimated using Poisson regression for areas with widespread and limited ZIKV transmission compared with areas without local ZIKV transmission. Defects with significantly higher prevalence in areas of widespread transmission were pooled, and PRs were calculated by quarter, comparing subsequent quarters to the first quarter (January-March 2016). Nine defects had significantly higher prevalence in areas of widespread transmission. The highest PRs were seen in intracranial calcifications (PR = 12.6, 95% CI [7.4, 21.3]), chorioretinal abnormalities (12.5 [7.1, 22.3]), brainstem abnormalities (9.3 [4.7, 18.4]), and cerebral/cortical atrophy (6.7 [4.2, 10.8]). The PR of the nine pooled defects was significantly higher in three quarters in areas with widespread transmission. The largest difference in prevalence was observed for defects consistently reported in infants with congenital ZIKV infection. Birth defects surveillance programs could consider monitoring a subset of birth defects potentially related to ZIKV in pregnancy.
- 4 January 2022
- Published by Wiley in Birth Defects Research
- Vol. 114 (2) , 80-89
Medicaid healthcare expenditures for infants with birth defects potentially related to Zika virus infection in North Carolina, 2011–2016
Background In 2016, Zika virus (ZIKV) was recognized as a human teratogen. North Carolina (NC) had no local transmission of ZIKV but infants with relevant birth defects, including severe brain anomalies, microcephaly, and eye abnormalities, require specialized care and services, the costs of which have not yet been quantified. The objective of this study is to examine NC Medicaid healthcare expenditures for infants with defects potentially related to ZIKV compared to infants with no reported defects. Methods Data sources for this retrospective cohort study include NC birth certificates, Birth Defects Monitoring Program data, and Medicaid enrollment and paid claims files. Infants with relevant defects were identified and expenditure ratios were calculated to compare distributions of estimated expenditures during the first year of life for infants with relevant defects and infants with no reported defects. Results This analysis included 551 infants with relevant defects and 365,318 infants with no reported defects born 2011–2016. Mean total expenditure per infant with defects was $69,244 (median $30,544) for the first year. The ratio of these expenditures relative to infants with no reported defects was 14.5. Expenditures for infants with select brain anomalies were greater than those for infants with select eye abnormalities only. Conclusions Infants with defects potentially related to ZIKV had substantially higher Medicaid expenditures than infants with no reported defects. These results may be informative in the event of a future outbreak and are a resource for program planning related to care for infants in NC.
- 4 January 2022
- Published by Wiley in Birth Defects Research
- Vol. 114 (2) , 80-89
Medicaid healthcare expenditures for infants with birth defects potentially related to Zika virus infection in North Carolina, 2011–2016
Background In 2016, Zika virus (ZIKV) was recognized as a human teratogen. North Carolina (NC) had no local transmission of ZIKV but infants with relevant birth defects, including severe brain anomalies, microcephaly, and eye abnormalities, require specialized care and services, the costs of which have not yet been quantified. The objective of this study is to examine NC Medicaid healthcare expenditures for infants with defects potentially related to ZIKV compared to infants with no reported defects. Methods Data sources for this retrospective cohort study include NC birth certificates, Birth Defects Monitoring Program data, and Medicaid enrollment and paid claims files. Infants with relevant defects were identified and expenditure ratios were calculated to compare distributions of estimated expenditures during the first year of life for infants with relevant defects and infants with no reported defects. Results This analysis included 551 infants with relevant defects and 365,318 infants with no reported defects born 2011–2016. Mean total expenditure per infant with defects was $69,244 (median $30,544) for the first year. The ratio of these expenditures relative to infants with no reported defects was 14.5. Expenditures for infants with select brain anomalies were greater than those for infants with select eye abnormalities only. Conclusions Infants with defects potentially related to ZIKV had substantially higher Medicaid expenditures than infants with no reported defects. These results may be informative in the event of a future outbreak and are a resource for program planning related to care for infants in NC.
- 10 March 2020
- Published by Wiley in Birth Defects Research
- Vol. 112 (6) , 503-514
Maternal diet as a risk factor for primary congenital glaucoma and defects of the anterior segment of the eye in the National Birth Defects Prevention Study
Primary congenital glaucoma (PCG) and anterior segment defects (ASDs) are rare ocular malformations diagnosed early in life which can cause blindness. Pathogenic variants in several genes have been linked to these conditions, but little is known about nongenetic risk factors. We investigated the association between maternal nutrition and PCG and ASDs in the National Birth Defects Prevention Study, a large population‐based, multicenter case–control study of major birth defects in the United States. Mothers of cases (n = 152) and control infants without a birth defect (n = 9,178) completed an interview which included a food frequency questionnaire capturing usual dietary intake in the year before pregnancy. Maternal nutrition was assessed through individual nutrient intake, calculating a Diet Quality Index for Pregnancy (DQI‐P) score for each mother, and using latent class analysis to empirically derive four dietary patterns. We calculated adjusted odds ratios (aORs) and 95% confidence intervals (CI) using logistic regression. The results for individual nutrients varied, with some having an inverse or U‐shaped pattern of association with increasing intake. The DQI‐P was not associated with risk of PCG and ASDs (aOR 0.91; CI 0.49–1.66, highest vs. lowest quartile). The dietary pattern analysis suggested lower odds among women with a Prudent and Mexican dietary pattern (aOR 0.82, 95% CI 0.52–1.29; aOR 0.80, 95% CI 0.36–1.78, respectively) compared to those with a Western dietary pattern. We found that higher intake of some nutrients and certain dietary patterns may be inversely associated with PCG and ASDs, though caution is urged due to imprecision of estimates.
- 10 March 2020
- Published by Wiley in Birth Defects Research
- Vol. 112 (6) , 503-514
Maternal diet as a risk factor for primary congenital glaucoma and defects of the anterior segment of the eye in the National Birth Defects Prevention Study
Primary congenital glaucoma (PCG) and anterior segment defects (ASDs) are rare ocular malformations diagnosed early in life which can cause blindness. Pathogenic variants in several genes have been linked to these conditions, but little is known about nongenetic risk factors. We investigated the association between maternal nutrition and PCG and ASDs in the National Birth Defects Prevention Study, a large population‐based, multicenter case–control study of major birth defects in the United States. Mothers of cases (n = 152) and control infants without a birth defect (n = 9,178) completed an interview which included a food frequency questionnaire capturing usual dietary intake in the year before pregnancy. Maternal nutrition was assessed through individual nutrient intake, calculating a Diet Quality Index for Pregnancy (DQI‐P) score for each mother, and using latent class analysis to empirically derive four dietary patterns. We calculated adjusted odds ratios (aORs) and 95% confidence intervals (CI) using logistic regression. The results for individual nutrients varied, with some having an inverse or U‐shaped pattern of association with increasing intake. The DQI‐P was not associated with risk of PCG and ASDs (aOR 0.91; CI 0.49–1.66, highest vs. lowest quartile). The dietary pattern analysis suggested lower odds among women with a Prudent and Mexican dietary pattern (aOR 0.82, 95% CI 0.52–1.29; aOR 0.80, 95% CI 0.36–1.78, respectively) compared to those with a Western dietary pattern. We found that higher intake of some nutrients and certain dietary patterns may be inversely associated with PCG and ASDs, though caution is urged due to imprecision of estimates.